Загрузка...
Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells
9-cis-UAB30 (UAB30) and Targretin are well-known RXR (retinoid X receptor) agonists. They were highly effective in decreasing the incidence of methylnitrosourea (MNU)-induced mammary cancers. However, whether the anti-mammary cancer effects of UAB30 or Targretin originate from the activation of RXR...
Сохранить в:
| Опубликовано в: : | Mol Carcinog |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4402118/ https://ncbi.nlm.nih.gov/pubmed/25328014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.22232 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|